PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 144 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $164,000 | -46.6% | 43,193 | -28.3% | 0.00% | – |
| Q4 2019 | $307,000 | -51.3% | 60,200 | -51.7% | 0.00% | – |
| Q3 2019 | $630,000 | -21.9% | 124,598 | -4.7% | 0.00% | – |
| Q2 2019 | $807,000 | -70.5% | 130,756 | -77.8% | 0.00% | -100.0% |
| Q1 2019 | $2,734,000 | -60.3% | 589,002 | -64.1% | 0.00% | -75.0% |
| Q4 2018 | $6,882,000 | -38.0% | 1,638,460 | -7.5% | 0.00% | -20.0% |
| Q3 2018 | $11,108,000 | +376.1% | 1,771,684 | +510.4% | 0.01% | +400.0% |
| Q2 2018 | $2,333,000 | +30.6% | 290,245 | +21.2% | 0.00% | – |
| Q1 2018 | $1,787,000 | +53.4% | 239,489 | +22.3% | 0.00% | – |
| Q4 2017 | $1,165,000 | +41.7% | 195,847 | +75.6% | 0.00% | – |
| Q3 2017 | $822,000 | +31.3% | 111,517 | +21.0% | 0.00% | – |
| Q2 2017 | $626,000 | -69.7% | 92,125 | -57.9% | 0.00% | -100.0% |
| Q1 2017 | $2,064,000 | +172.3% | 218,651 | +149.3% | 0.00% | – |
| Q4 2016 | $758,000 | -40.8% | 87,704 | -56.7% | 0.00% | -100.0% |
| Q3 2016 | $1,281,000 | +1181.0% | 202,416 | +783.6% | 0.00% | – |
| Q1 2016 | $100,000 | -80.3% | 22,909 | -74.1% | 0.00% | – |
| Q3 2015 | $507,000 | -4.7% | 88,594 | +24.2% | 0.00% | – |
| Q2 2015 | $532,000 | +131.3% | 71,325 | +85.9% | 0.00% | – |
| Q1 2015 | $230,000 | -80.7% | 38,375 | -75.7% | 0.00% | -100.0% |
| Q4 2014 | $1,191,000 | +635.2% | 157,629 | +405.9% | 0.00% | – |
| Q3 2014 | $162,000 | +422.6% | 31,161 | +337.0% | 0.00% | – |
| Q2 2014 | $31,000 | -54.4% | 7,130 | -57.4% | 0.00% | – |
| Q1 2014 | $68,000 | -86.7% | 16,725 | -82.6% | 0.00% | -100.0% |
| Q4 2013 | $512,000 | -34.2% | 96,117 | -37.8% | 0.00% | 0.0% |
| Q3 2013 | $778,000 | -56.1% | 154,547 | -61.1% | 0.00% | -66.7% |
| Q2 2013 | $1,772,000 | – | 397,254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|